Cord Blood Bankers are. Angie Yost, MT(ASCP) CM 2016 ASCLS-MO CLMA Spring Meeting

Size: px
Start display at page:

Download "Cord Blood Bankers are. Angie Yost, MT(ASCP) CM 2016 ASCLS-MO CLMA Spring Meeting"

Transcription

1 Cord Blood Bankers are Angie Yost, MT(ASCP) CM 2016 ASCLS-MO CLMA Spring Meeting

2 Objectives Cord blood 101 Manufacturing and cryopreservation Characterization testing

3 Why Do We Need Cord Blood? Each year, thousands of people are diagnosed with leukemia, lymphoma, or immune system or genetic (inherited) disorders. People with these diseases have abnormal or non-functional blood-forming cells. A stem cell transplant replaces a patient s diseased bloodforming cells with healthy cells. Healthy cells from another individual must be matched.

4 Stem Cell Sources There are 3 primary sources of adult stem cells for patients needing transplant. Bone Marrow Peripheral Blood Cord Blood

5 What is Cord Blood? Blood that remains in the umbilical cord and placenta after a child is born Rich source of adult stem cells Similar to those found in bone marrow Obtained from a developed person Self-renewing source of life-long production of red blood cells, platelets, and white blood cells Non-controversial Collected after baby is born No harm to mother or baby

6 What is Cord Blood?

7 What Are The Benefits of Cord Blood? Abundant resource: 4 million births/year in the U.S. Placental barrier reduces environmental exposure & contamination from viruses Easier access when needed-prompt access-low attrition Lower rate of rejection More flexible matches

8 What Diseases Can Be Treated With Cord Blood? Acute and Chronic Leukemias Congenital Immune System Disorders Histiocytic Disorders Inherited Erythrocyte Abnormalities Liposomal Storage Diseases Lymphoproliferative Disorders Myelodysplastic Syndromes Myeloproliferative Disorders Other Inherited Disorders Plasma Cell Disorders Phagocyte Disorders Solid Tumors/Other Malignancies Stem Cell Disorders

9 How Are Public And Private Cord Blood Banks Different? Public cord blood bank No cost to donor Units available to unrelated recipients worldwide by HLA match Required testing for infectious diseases Subject to stringent regulations for good manufacturing practices Private cord blood bank Initial collection fee and annual storage fee Units only available to donor and donor s family Infectious disease testing not required for autologous donation Minimum regulations since future use not based on disease treatment

10 How is Cord Blood Regulated?

11 How is Cord Blood Regulated? Due to intended use in allogeneic recipients, cord blood is classified as a biologic drug Regulated under the more stringent current Good Manufacturing Practice (cgmp) rules & biologics standards similar to pharmaceuticals Each cord = unique biological component; cells vs. chemicals Lot sizes = single patient lot vs thousands of tablets Manufacturing process controls = drugs can be terminally sterilized; cord blood manufacturers rely on aseptic processing

12 How Are Cord Blood Units Selected for Manufacture? Selection Criteria Weight (indicator of volume) Total Nucleated Cell count (TNC) (WBC s + NRBC s) Maternal history questionnaire review Maternal tubes for infectious disease testing

13 From Cord Blood to HPC, Cord Blood

14 From Cord Blood to HPC, Cord Blood

15 How is Cord Blood Cryopreserved? DMSO Controlled Rate Freezer Liquid Nitrogen Storage

16 How is Cord Blood Cryopreserved?

17 How is Cord Blood Characterized? Run samples on hematology analyzer to evaluate WBC and NRBC counts

18 How is Cord Blood Characterized? Run samples on flow cytometer to evaluate WBC and HPC count

19 How is Cord Blood Characterized? Perform trypan blue viability counts

20 How is Cord Blood Characterized? Plate, incubate, and read CFU assays CFU-E BFU-E CFU-GM CFU-GEMM

21 How is Cord Blood Characterized? Perform preand postprocessing ABO/Rh typing

22 How is Cord Blood Characterized? Prepare Whatman filter paper cards for HLA typing

23 How is Cord Blood Characterized? hemoglobinopathy Prepare samples for hemoglobinopathy testing

24 How is Cord Blood Characterized? Inoculate, incubate, and evaluate blood bottle cultures (aerobic, anaerobic, and fungal)

25 How is Cord Blood Characterized? Environmental monitoring of personnel and work spaces

26 How is Cord Blood Characterized?

27 How is Cord Blood Characterized?

28 How is Cord Blood Characterized?

29 How is Cord Blood Characterized? Prepare maternal samples for infectious disease testing

30 How is Cord Blood Characterized? Freeze aliquots of pre- and postprocessing, as well as maternal samples

31 The REAL Heroes

32 Why We Do What We Do! The chemo I had when I was eight years old killed my cancer, but along with it my bone marrow. I wasn t making anything on my own anymore. A bone marrow transplant could repopulate her blood-forming cells, but her parents and two younger sisters did not match her blood type. Before we could worry, they told us, But we have cord blood.

33 Why We Do What We Do! Now I want to help other people.

34 Find Out More On Facebook

35 Thank you!

OneMatch Stem Cell and Marrow Network. Training Guide

OneMatch Stem Cell and Marrow Network. Training Guide OneMatch Stem Cell and Marrow Network Training Guide What is OneMatch all about? OneMatch is a Canadian Program that matches and coordinates the collection of stem cells from potential donors to help save

More information

BMTCN REVIEW COURSE PRE-TRANSPLANT CARE

BMTCN REVIEW COURSE PRE-TRANSPLANT CARE BMTCN REVIEW COURSE PRE-TRANSPLANT CARE Jennifer Shamai MS, RN, AOCNS, BMTCN Professional Practice Leader Department of Clinical Practice And Professional Education Click How to edit the Master Experts

More information

Hematopoietic Stem Cells, Stem Cell Processing, and Transplantation

Hematopoietic Stem Cells, Stem Cell Processing, and Transplantation Hematopoietic Stem Cells, Stem Cell Processing, and Joseph (Yossi) Schwartz, M irector, Hemotherapy and Stem Cell Processing Facility Bone Marrow Can Cure: Leukemia Lymphoma Multiple Myeloma Genetic iseases:

More information

Hematopoiesis i starts from. HPC differentiates t to sequentially more mature. HPC circulate in very low

Hematopoiesis i starts from. HPC differentiates t to sequentially more mature. HPC circulate in very low Upstate Cord Blood Bank Hematopoietic Progenitor Cells Hematopoiesis i starts from self renewing HPC HPC differentiates t to sequentially more mature blood cells HPC circulate in very low numbers in adults

More information

Blood and Marrow Transplant (BMT) for Sickle Cell Disease

Blood and Marrow Transplant (BMT) for Sickle Cell Disease Blood and Marrow Transplant (BMT) for Sickle Cell Disease Rhiannon is now cured of sickle cell disease after BMT. Blood and marrow transplant (BMT) is a proven cure for sickle cell disease. This handbook

More information

Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease

Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children s Research Hospital Departments of Hematology, Patient

More information

What are stem cells? A stem cell can differentiate into any one of 220 different specialised cells in the body STEM CELLS

What are stem cells? A stem cell can differentiate into any one of 220 different specialised cells in the body STEM CELLS What are stem cells? Stem cells are often called MASTER CELLS, and form the foundation for your entire body as building blocks for the blood, immune system, tissue and organs. They can REPLICATE or REGENERATE

More information

CORD BLOOD TRANSPLANTATION STUDY CBU EXCLUSION AND QUARANTINE RELEASE FORM

CORD BLOOD TRANSPLANTATION STUDY CBU EXCLUSION AND QUARANTINE RELEASE FORM (Any answer of Yes indicates exclusion) 1. Informed Consent and Maternal/Infant Demographics a. Lack of confirmation of signed and witnessed informed consent 1 Yes 2 No Is the following information missing

More information

LEGISLATIVE FRAMEWORKS AND ETHICS OF DONATION. Jeff Szer, Royal Melbourne Hospital, Australia

LEGISLATIVE FRAMEWORKS AND ETHICS OF DONATION. Jeff Szer, Royal Melbourne Hospital, Australia LEGISLATIVE FRAMEWORKS AND ETHICS OF DONATION Jeff Szer, Royal Melbourne Hospital, Australia Donation of HPC Autologous HPC-A HPC-M Allogeneic Family member Volunteer Unrelated HPC-A HPC-M HPC-C Ethical

More information

What the Transfusion Scientist should know about Stem Cells. Dr Claire Wiggins BBTS September 2017

What the Transfusion Scientist should know about Stem Cells. Dr Claire Wiggins BBTS September 2017 What the Transfusion Scientist should know about Stem Cells Dr Claire Wiggins BBTS September 2017 What is a stem cell? Undifferentiated cell Can divide and self renew for long periods Differentiate into

More information

CryoStor CS2, CS5 and CS10 FREEZE MEDIA

CryoStor CS2, CS5 and CS10 FREEZE MEDIA CryoStor CS2, CS5 and CS10 FREEZE MEDIA Pre-Formulated Serum-Free Protein-Free cgmp Manufactured FDA Master File Sterility, Endotoxin, and Cell-Based Release Testing CryoStor, a series of cell-specific,

More information

The Value of Community- Based Initiatives

The Value of Community- Based Initiatives The Value of Community- Based Initiatives Saving Lives Through Blood and Marrow transplantation Jeffrey Chell, MD 1 What is Bone Marrow? The blood-forming cells in the hollow portion of our bones Looks

More information

Applications of Cord Blood Stem Cells

Applications of Cord Blood Stem Cells Applications of Cord Blood Stem Cells over 360 families have used their banked cord blood in transplant or regenerative medicine research. 1 88 ViaCord has released over 360 units for transplant or infusion

More information

Neutrophil Recovery: The. Posttransplant Recovery. Bus11_1.ppt

Neutrophil Recovery: The. Posttransplant Recovery. Bus11_1.ppt Neutrophil Recovery: The First Step in Posttransplant Recovery No conflicts of interest to disclose Bus11_1.ppt Blood is Made in the Bone Marrow Blood Stem Cell Pre-B White cells B Lymphocyte T Lymphocyte

More information

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the

More information

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the

More information

Donating your baby s cord to a public cord blood bank can save lives globally.

Donating your baby s cord to a public cord blood bank can save lives globally. Donating your baby s cord to a public cord blood bank can save lives globally. You can play an important role in saving lives by donating the blood contained in your baby s umbilical cord to LifeCord,

More information

Implementation of the Stem Cell Therapeutic and Research Act of 2005

Implementation of the Stem Cell Therapeutic and Research Act of 2005 Implementation of the Stem Cell Therapeutic and Research Act of 2005 The 6 th Annual Somatic Cell Therapy Symposium Bethesda, MD September 26, 2006 James F. Burdick, M.D. U.S. Department of Health and

More information

Trends in Hematopoietic Cell Transplantation. AAMAC Patient Education Day Oct 2014

Trends in Hematopoietic Cell Transplantation. AAMAC Patient Education Day Oct 2014 Trends in Hematopoietic Cell Transplantation AAMAC Patient Education Day Oct 2014 Objectives Review the principles behind allogeneic stem cell transplantation Outline the process of transplant, some of

More information

Stem Cell Transplantation for Severe Aplastic Anemia

Stem Cell Transplantation for Severe Aplastic Anemia Number of Transplants 10/24/2011 Stem Cell Transplantation for Severe Aplastic Anemia Claudio Anasetti, MD Professor of Oncology and Medicine Chair, Blood and Marrow Transplant Dpt Moffitt Cancer Center

More information

2/26/2016. Types of Stem Cells: Agenda. Objectives

2/26/2016. Types of Stem Cells: Agenda. Objectives PAMET, March 5, 2016 Umbilical Cord Blood for Public Banking and Research Regenerative Medicine: Curing disease by repairing or replacing organs and systems through cellular and tissue engineering Bladder

More information

Haplo vs Cord vs URD Debate

Haplo vs Cord vs URD Debate 3rd Annual ASBMT Regional Conference for NPs, PAs and Fellows Haplo vs Cord vs URD Debate Claudio G. Brunstein Associate Professor University of Minnesota Medical School Take home message Finding a donor

More information

CHAPTER 3 LABORATORY PROCEDURES

CHAPTER 3 LABORATORY PROCEDURES CHAPTER 3 LABORATORY PROCEDURES CHAPTER 3 LABORATORY PROCEDURES 3.1 HLA TYPING Molecular HLA typing will be performed for all donor cord blood units and patients in the three reference laboratories identified

More information

Cord Blood Banking. The Birth of a New Field

Cord Blood Banking. The Birth of a New Field FEATURE Karen Titus Cord Blood Banking The Birth of a New Field iven the great availability of cord blood every new birth represents a possible source it's little wonder this blood product has drawn intense

More information

Factors Influencing Haematopoietic Progenitor cell transplant outcome Optimising donor selection

Factors Influencing Haematopoietic Progenitor cell transplant outcome Optimising donor selection Factors Influencing Haematopoietic Progenitor cell transplant outcome Optimising donor selection Alison Logan Transplantation Laboratory Manchester Royal Infirmary Haematopoietic progenitor cell transplants

More information

Analysis of the Viability of Umbilical Cord blood Stem Cells. Sachdeva N

Analysis of the Viability of Umbilical Cord blood Stem Cells. Sachdeva N Jsrm/Vol5No.11, 2009 Original Article Analysis of the of Umbilical Cord blood Stem Cells Sachdeva N Dr. Neelam Sachdeva Reader, Department of Zoology, Gargi College, University of Delhi, Siri Fort Road,

More information

Leukine. Leukine (sargramostim) Description

Leukine. Leukine (sargramostim) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.85.08 Subject: Leukine Page: 1 of 5 Last Review Date: September 15, 2017 Leukine Description Leukine

More information

Dr.PSRK.Sastry MD, ECMO

Dr.PSRK.Sastry MD, ECMO Peripheral blood stem cell transplantation (Haematopoietic stem cell transplantation) Dr.PSRK.Sastry MD, ECMO Consultant, Medical Oncology Kokilaben Dhirubhai Ambani Hospital Normal hematopoiesis Historical

More information

About OMICS Group Conferences

About OMICS Group Conferences About OMICS Group OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of

More information

The role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness.

The role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness. The role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness. Robert Liwski, MD, PhD, FRCPC Medical Director HLA Typing Laboratory Department of Pathology Dalhousie

More information

Allogeneic donor selection and blood collection. by Mohammed Abu-basha

Allogeneic donor selection and blood collection. by Mohammed Abu-basha Allogeneic donor selection and blood collection 1 An allogeneic (also called homologous) donation (allo- from the Greek meaning "other") is when a donor gives blood for storage at a blood bank for transfusion

More information

Samples Available for Recipient Only. Samples Available for Recipient and Donor

Samples Available for Recipient Only. Samples Available for Recipient and Donor Unrelated HCT Research Sample Inventory - Summary for First Allogeneic Transplants in CRF and TED with biospecimens available through the CIBMTR Repository stratified by availability of paired samples,

More information

Graft processing across Africa: What is available? Jackie Thomson Alberts cellular therapy Pretoria

Graft processing across Africa: What is available? Jackie Thomson Alberts cellular therapy Pretoria Graft processing across Africa: What is available? Jackie Thomson Alberts cellular therapy Pretoria Purpose of the talk range of activities, staffing, any problems you face both scientifically, logistically

More information

What s a Transplant? What s not?

What s a Transplant? What s not? What s a Transplant? What s not? How to report the difference? Daniel Weisdorf MD University of Minnesota Anti-cancer effects of BMT or PBSCT [HSCT] Kill the cancer Save the patient Restore immunocompetence

More information

General Terms: Appendix B. National Marrow Donor Program and The Medical College of Wisconsin

General Terms: Appendix B. National Marrow Donor Program and The Medical College of Wisconsin Glossary of Terms This appendix is divided into two sections. The first section, General Terms, defines terms used throughout the CIBMTR data collection forms. The second section, FormsNet TM 2 Terms,

More information

Samples Available for Recipient and Donor

Samples Available for Recipient and Donor Unrelated HCT Research Sample Inventory - Summary for First Allogeneic Transplants in CRF and TED with biospecimens available through the CIBMTR Repository stratified by availability of paired samples,

More information

Samples Available for Recipient Only. Samples Available for Recipient and Donor

Samples Available for Recipient Only. Samples Available for Recipient and Donor Unrelated HCT Research Sample Inventory - Summary for First Allogeneic Transplants in CRF and TED with biospecimens available through the CIBMTR Repository stratified by availability of paired samples,

More information

Bone Marrow Transplantation and the Potential Role of Iomab-B

Bone Marrow Transplantation and the Potential Role of Iomab-B Bone Marrow Transplantation and the Potential Role of Iomab-B Hillard M. Lazarus, MD, FACP Professor of Medicine, Director of Novel Cell Therapy Case Western Reserve University 1 Hematopoietic Cell Transplantation

More information

Transfusion Medicine (Comprehensive, Limited) J, J1

Transfusion Medicine (Comprehensive, Limited) J, J1 www.cap.org Transfusion Medicine Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS). Transfusion Medicine (Comprehensive, Limited)

More information

Hematopoietic Stem Cell Therapy

Hematopoietic Stem Cell Therapy Hematopoietic Stem Cell Therapy Grace Totoe, MBChB, SBB CME August 2012 Accra-Ghana Hematopoietic Stem Cells Cells capable of self renewal and differentiation into all blood cell lineages Objectives Historical

More information

Sterility Testing of Peripheral Blood Stem cell (PBSC) harvests in a Tertiary Oncology Setup

Sterility Testing of Peripheral Blood Stem cell (PBSC) harvests in a Tertiary Oncology Setup Sterility Testing of Peripheral Blood Stem cell (PBSC) harvests in a Tertiary Oncology Setup Bankar S 1, Tirlotkar A 1, Ojha S 1, Bhat V 2,Kannan S 3, Rajadhyaksha S 1 1. Department of Transfusion Medicine,

More information

Getting in touch. Everything you need to know. (and probably a bit more too!)

Getting in touch. Everything you need to know. (and probably a bit more too!) Getting in touch For more information about collecting and storing your child s umbilical cord stem cells, please get in touch with our customer care team who can answer any questions you might have: Telephone:

More information

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY 1. Module/unit Code II. 1.2. 2. Module/unit Title Hematology 3. Subject Field Internal Diseases Group 4. Faculty/Department General Medicine, Department of Hematology 5. Programme(s) to which the Doctor

More information

Give Birth to Hope: An Unique Approach to Public Cord Blood Donation

Give Birth to Hope: An Unique Approach to Public Cord Blood Donation Give Birth to Hope: An Unique Approach to Public Cord Blood Donation The Public Health Nursing and Professional Development Unit, North Carolina Division of Public Health, is approved as a provider of

More information

WISKOTT-ALDRICH SYNDROME. An X-linked Primary Immunodeficiency

WISKOTT-ALDRICH SYNDROME. An X-linked Primary Immunodeficiency WISKOTT-ALDRICH SYNDROME An X-linked Primary Immunodeficiency WHAT IS WISKOTT ALDRICH SYNDROME? Wiskott-Aldrich Syndrome (WAS) is a serious medical condition that causes problems both with the immune system

More information

Introduction to Hematopoietic Stem Cell Transplantation

Introduction to Hematopoietic Stem Cell Transplantation Faculty Disclosures Introduction to Hematopoietic Stem Cell Transplantation Nothing to disclose Jeanne McCarthy-Kaiser, PharmD, BCOP Clinical Pharmacist, Autologous Stem Cell Transplant/Long- Term Follow-Up

More information

Health Sciences 1111 Module 11 Blood and Lymphatics LAB 11. Watch the video Our Immune System and answer the questions on your worksheet.

Health Sciences 1111 Module 11 Blood and Lymphatics LAB 11. Watch the video Our Immune System and answer the questions on your worksheet. Health Sciences 1111 Module 11 Blood and Lymphatics LAB 11 Watch the video Our Immune System and answer the questions on your worksheet. Open Internet Explorer o Go to the Health Sciences Website* and

More information

Cord Blood Stem Cell Banking and Transplantation

Cord Blood Stem Cell Banking and Transplantation Cord Blood Stem Cell Banking and Transplantation JOHN W. ADAMSON New York Blood Center, New York, New York, USA Key Words. Cord blood Stem cells Cord blood banking Cord blood transplantation. Cord blood.stern

More information

Recommended Timing for Transplant Consultation

Recommended Timing for Transplant Consultation REFERRAL GUIDELINES Recommended Timing for Transplant Consultation Published jointly by the National Marrow Donor Program /Be The Match and the American Society for Blood and Marrow Transplantation BeTheMatchClinical.org

More information

Hematopoietic Stem Cells

Hematopoietic Stem Cells Hematopoietic Stem Cells, Stem Cell Processing, and Joseph (Yossi) Schwartz, M irector, Hemotherapy and Stem Cell Processing Facility E-mail: js2745@columbia.edu Hematopoietic Stem Cells Sustain hematopoiesis

More information

Leukine. Leukine (sargramostim) Description

Leukine. Leukine (sargramostim) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Leukine Page: 1 of 6 Last Review Date: November 30, 2018 Leukine Description Leukine (sargramostim)

More information

Potency & Release Testing for unrelated donor cord blood units

Potency & Release Testing for unrelated donor cord blood units Potency & Release Testing for unrelated donor cord blood units Joanne Kurtzberg, MD Robertson Cell and Translational Therapy Program Pediatric Blood and Marrow Transplant Program Carolinas Cord Blood Bank

More information

Study for the improvement of umbilical cord blood sampling using a new trial apparatus

Study for the improvement of umbilical cord blood sampling using a new trial apparatus bs_bs_banner doi:10.1111/jog.12179 J. Obstet. Gynaecol. Res. Vol. 40, No. 2: 405 409, February 2014 Study for the improvement of umbilical cord blood sampling using a new trial apparatus Naoki Masaoka

More information

5/9/2018. Bone marrow failure diseases (aplastic anemia) can be cured by providing a source of new marrow

5/9/2018. Bone marrow failure diseases (aplastic anemia) can be cured by providing a source of new marrow 5/9/2018 or Stem Cell Harvest Where we are now, and What s Coming AA MDS International Foundation Indianapolis IN Luke Akard MD May 19, 2018 Infusion Transplant Conditioning Treatment 2-7 days STEM CELL

More information

Blood Components & Indications for Transfusion. Neda Kalhor

Blood Components & Indications for Transfusion. Neda Kalhor Blood Components & Indications for Transfusion Neda Kalhor Blood products Cellular Components: Red blood cells - Leukocyte-reduced RBCs - Washed RBCs - Irradiated RBCs Platelets - Random-donor platelets

More information

Stem cells. -Dr Dinesh Bhurani, MD, DM, FRCPA. Rajiv Gandhi Cancer Institute, Delhi, -Director, Department of Haematology and BMT

Stem cells. -Dr Dinesh Bhurani, MD, DM, FRCPA. Rajiv Gandhi Cancer Institute, Delhi, -Director, Department of Haematology and BMT Stem cells -Dr Dinesh Bhurani, MD, DM, FRCPA -Director, Department of Haematology and BMT Rajiv Gandhi Cancer Institute, Delhi, Flow of presentation Update on stem cell uses Haematopoietic stem cell transplantation

More information

Specimen Collection Requirements. Test Name Specimen Type Storage Time Storage Conditions

Specimen Collection Requirements. Test Name Specimen Type Storage Time Storage Conditions 1 Specimen Collection Requirements PURPOSE/PRINCIPLE: To outline proper specimen collection for molecular HLA testing, including tube type, minimum specimen amount, proper tube and requisition labeling,

More information

CELLULAR THERAPY QUIZ. Correct answers and rationale

CELLULAR THERAPY QUIZ. Correct answers and rationale CELLULAR THERAPY QUIZ Correct answers and rationale In January 2018, registered cellular therapy (CT) facilities were asked to participate in the quiz to determine the educational needs of the users regarding

More information

Stem cell transplantation. Dr Mohammed Karodia NHLS & UP

Stem cell transplantation. Dr Mohammed Karodia NHLS & UP Stem cell transplantation Dr Mohammed Karodia NHLS & UP The use of haemopoeitic stem cells from a donor harvested from peripheral blood or bone marrow, to repopulate recipient bone marrow. Allogeneic From

More information

Just the FACTS: You can help! Join the NMDP Registry. Vital Statistics

Just the FACTS: You can help! Join the NMDP Registry. Vital Statistics Just the FACTS: You can help! Join the NMDP Registry Vital Statistics Every year, more than 10,000 men, women and children get life-threatening diseases such as leukemia and lymphoma, and do not have a

More information

Comparing outcome between Belgian haematopoietic stem cell transplant centres

Comparing outcome between Belgian haematopoietic stem cell transplant centres ENCR2016, 2014/06/10 1 Comparing outcome between Belgian haematopoietic stem cell transplant centres Gilles Macq 1, Evelien Vaes 1, Geert Silversmit 1, Marijke Vanspauwen 1, Liesbet Van Eycken 1 & Yves

More information

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,

More information

WHO- Global perspective of hematopoieitic stem cell transplantation

WHO- Global perspective of hematopoieitic stem cell transplantation WHO- Global perspective of hematopoieitic stem cell transplantation José R. Núñez MD, PhD WHO Dietger Niederwieser MD University Hospital, Leipzig, Germany 2 3 4 5 Over the past 50 years, the transplantation

More information

The National Marrow Donor Program. Graft Sources for Hematopoietic Cell Transplantation. Simon Bostic, URD Transplant Recipient

The National Marrow Donor Program. Graft Sources for Hematopoietic Cell Transplantation. Simon Bostic, URD Transplant Recipient 1988 199 1992 1994 1996 1998 2 22 24 26 28 21 212 214 216 218 Adult Donors Cord Blood Units The National Donor Program Graft Sources for Hematopoietic Cell Transplantation Dennis L. Confer, MD Chief Medical

More information

FREQUENTLY ASKED QUESTIONS BONE MARROW / STEM CELL DONATION

FREQUENTLY ASKED QUESTIONS BONE MARROW / STEM CELL DONATION FREQUENTLY ASKED QUESTIONS BONE MARROW / STEM CELL DONATION About Anthony Nolan Anthony Nolan is a pioneering charity that saves the lives of people with blood cancer who need a bone marrow, or stem cell,

More information

4nd Patient and Family Day

4nd Patient and Family Day 4nd Patient and Family Day EBMT Slide template Barcelona 7 February 2008 EBMT 2010 Vienna, Austria ; www.ebmt.org History of Stem Cell Transplantation Appelbaum et al, NEJM 2006 What is EBMT? Scientific,

More information

Need considerable resources material and human.

Need considerable resources material and human. TRAN VAN BINH INTRODUCTION Hematopoietic Stem cell transplantation: the best way to manage Malignancies and non Malignant blood disorders. Need considerable resources material and human. In developping

More information

PERIPHERAL BLOOD STEM CELL DONATION AWARENESS AMONG COLLEGE STUDENTS

PERIPHERAL BLOOD STEM CELL DONATION AWARENESS AMONG COLLEGE STUDENTS PERIPHERAL BLOOD STEM CELL DONATION AWARENESS AMONG COLLEGE STUDENTS Ms.Sruthy.T.Varghese 1, Mrs. Moly Hem 2 1 II Year MSc Nursing, Amrita College of Nursing, AIMS, Kochi, (India) 2 Associate Professor,

More information

Hematopoetic Stem Cell Therapies in TURKIYE

Hematopoetic Stem Cell Therapies in TURKIYE Hematopoetic Stem Cell Therapies in TURKIYE World Location of transplant centers participating in CIBMTR (2010) Dr. Mustafa ÇETİN Mustafa CETIN, M.D. Erciyes University Medical Faculty Kayseri-TURKIYE

More information

Stem Cell Transplant (Peripheral Blood, Bone Marrow, and Cord Blood Transplants)

Stem Cell Transplant (Peripheral Blood, Bone Marrow, and Cord Blood Transplants) Stem Cell Transplant (Peripheral Blood, Bone Marrow, and Cord Blood Transplants) What we ll cover here This document reviews bone marrow transplants and different types of stem cell transplants used to

More information

Preventing CMV Transmission through Leukodepletion

Preventing CMV Transmission through Leukodepletion Preventing CMV Transmission through Leukodepletion Possibility & Facts Prof.S.B.Rajadhyaksha, MD,DTM,PGDMLS Head, Dept. of Transfusion Medicine Tata Memorial Hospital, Mumbai 1 Donor Leukocytes Linked

More information

Regence. Next Review: 08/2019 Last Review: 08/2018 Medicare Link(s) Revised: 10/01/2018 IMPORTANT REMINDER

Regence. Next Review: 08/2019 Last Review: 08/2018 Medicare Link(s) Revised: 10/01/2018 IMPORTANT REMINDER Regence Medicare Advantage Policy Manual Policy ID: M-TRA45 Stem Cell / Bone Marrow Transplants Published: 10/01/2018 Next Review: 08/2019 Last Review: 08/2018 Medicare Link(s) Revised: 10/01/2018 IMPORTANT

More information

Media Fill Test Kits. Manufactured by. Making USP <797> compliance easy!

Media Fill Test Kits. Manufactured by. Making USP <797> compliance easy! Media Fill Test Kits Manufactured by Making USP compliance easy! Compliance was never so easy! Microbial Contamination Testing for CSPs Hardy Diagnostics offers all the products you need to easily

More information

Na#onal Neutropenia Network Family Conference July 12, 2014

Na#onal Neutropenia Network Family Conference July 12, 2014 Na#onal Neutropenia Network Family Conference July 12, 2014 Jim Connelly, MD Assistant Professor of Pediatrics and Communicable Diseases Blood and Marrow Transplant Program University of Michigan Transplant

More information

Bone Marrow Transplantation in Myelodysplastic Syndromes. An overview for the Myelodysplasia Support Group of Ottawa

Bone Marrow Transplantation in Myelodysplastic Syndromes. An overview for the Myelodysplasia Support Group of Ottawa Bone Marrow Transplantation in Myelodysplastic Syndromes An overview for the Myelodysplasia Support Group of Ottawa Objectives Provide brief review of marrow failure Re emphasize the importance of predictions

More information

Human Umbilical Vein Endothelial Cell Manual

Human Umbilical Vein Endothelial Cell Manual Human Umbilical Vein Endothelial Cell Manual INSTRUCTION MANUAL ZBM0079.03 SHIPPING CONDITIONS Human Umbilical Vein Endothelial Cells, cryopreserved Cryopreserved cells are shipped on dry ice and should

More information

Stem Cell Research 101:

Stem Cell Research 101: Stem Cell Research 101: The Consumer s Guide to Stem Cell Research and advanced Regenerative therapies Here is What YOu will learn in this free guide about stem Cells... The 2 Main Types Of Stem Cell Treatments

More information

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017 Overview of Aplastic Anemia Overview of Aplastic Anemia Peter Westervelt, MD, PhD Professor of Medicine Chief, BMT/Leukemia Section Washington University School of Medicine Epidemiology Normal hematopoiesis

More information

Topics and Controversies in Newborn Stem Cell Medicine

Topics and Controversies in Newborn Stem Cell Medicine Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

Graft source and Stem cell collection SULADA PUKIAT, MD

Graft source and Stem cell collection SULADA PUKIAT, MD + Graft source and Stem cell collection SULADA PUKIAT, MD + Hematopoietic stem cells Hematopoietic stem cells are CD34 + /CD45 dim /SSC low /FSClow to intermediate Neutrophils Bone NK cells T cells Basophils

More information

Introduction to Clinical Hematopoietic Cell Transplantation (HCT) George Chen, MD Thursday, May 03, 2018

Introduction to Clinical Hematopoietic Cell Transplantation (HCT) George Chen, MD Thursday, May 03, 2018 Introduction to Clinical Hematopoietic Cell Transplantation (HCT) George Chen, MD Thursday, May 03, 2018 The transfer of hematopoietic progenitor and stem cells for therapeutic purposes Hematopoietic Cell

More information

XIV. HLA AND TRANSPLANTATION MEDICINE

XIV. HLA AND TRANSPLANTATION MEDICINE XIV. HLA AND TRANSPLANTATION MEDICINE A. Introduction 1. The HLA system includes a complex array of genes and their molecular products that are involved in immune regulation and cellular differentiation.

More information

European actions in the field of transplantation & blood transfusion

European actions in the field of transplantation & blood transfusion European actions in the field of transplantation & blood transfusion Andrzej Rys Director Directorate Health Systems and Products Madrid, 27 June 2013 1 Blood Tissues and cells Organs 2 Blood transfusion

More information

Cord Blood: Best Practices in Counseling, Collection, and Banking

Cord Blood: Best Practices in Counseling, Collection, and Banking Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT DEPARTMENT OF BONE MARROW TRANSPLANT About Narayana Health City Headquartered in Bangalore, Narayana Health has a network of hospitals across India witha

More information

Stem cell transplantation for haemoglobinopathies. Dr P J Darbyshire Birmingham Childrens Hospital

Stem cell transplantation for haemoglobinopathies. Dr P J Darbyshire Birmingham Childrens Hospital Stem cell transplantation for haemoglobinopathies Dr P J Darbyshire Birmingham Childrens Hospital Survival by Cohort of Birth (N=977) 1.00 85-97 80-84 75-79 70-74 0.75 Survival Probability 0.50 0.25 P

More information

Haploidentical Transplantation: The Answer to our Donor Problems? Mary M. Horowitz, MD, MS CIBMTR, Medical College of Wisconsin January 2017

Haploidentical Transplantation: The Answer to our Donor Problems? Mary M. Horowitz, MD, MS CIBMTR, Medical College of Wisconsin January 2017 Haploidentical Transplantation: The Answer to our Donor Problems? Mary M. Horowitz, MD, MS CIBMTR, Medical College of Wisconsin January 2017 Allogeneic Transplant Recipients in the US, by Donor Type 9000

More information

UMBILICAL CORD BLOOD STEM CELLS EXPANDED IN THE PRESENCE OF NICOTINAMIDE (NICORD) PROVIDE LONG TERM MULITI-LINEAGE ENGRAFTMENT

UMBILICAL CORD BLOOD STEM CELLS EXPANDED IN THE PRESENCE OF NICOTINAMIDE (NICORD) PROVIDE LONG TERM MULITI-LINEAGE ENGRAFTMENT UMBILICAL CORD BLOOD STEM CELLS EXPANDED IN THE PRESENCE OF NICOTINAMIDE (NICORD) PROVIDE LONG TERM MULITI-LINEAGE ENGRAFTMENT Mitchell E. Horwitz, MD Duke University Medical Center Duke Cancer Institute

More information

READ BEFORE USING. Contents:

READ BEFORE USING. Contents: READ BEFORE USING The Liveyon ReGen product is derived from voluntarily donated human umbilical cord. ReGen can only be sold to, and used by licensed physicians. Read this entire package insert carefully

More information

Understanding the role of ex vivo T cell depletion

Understanding the role of ex vivo T cell depletion Prevention of graftversus-host disease (GVHD) Understanding the role of ex vivo T cell depletion Information for patients undergoing allogeneic stem cell transplantation in AML and their families 2 This

More information

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood?

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood? What is blood transfusion? A blood transfusion is a safe, common procedure in which blood is given through an intravenous (IV) line in one of the blood vessels. A blood transfusion usually takes two to

More information

USER INSTRUCTIONS HPC, Cord Blood Donor History Questionnaire. Table of Contents

USER INSTRUCTIONS HPC, Cord Blood Donor History Questionnaire. Table of Contents Page 1 of 9 USER INSTRUCTIONS HPC, Cord Blood Donor History Questionnaire Table of Contents Purpose Introduction Capture Questions Methods of Administration DHQ Materials Structure and Content Reformatting

More information

CHAPTER 2 PROTOCOL DESIGN

CHAPTER 2 PROTOCOL DESIGN CHAPTER 2 PROTOCOL DESIGN CHAPTER 2 PROTOCOL DESIGN 2.1 ELIGIBILITY CRITERIA Participants fulfilling the following criteria will be eligible for enrollment in the protocol: 1. Participant is diagnosed

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Hematopoietic Cell Transplantation for CLL and SLL File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_cell_transplantation_for_cll_and_sll 2/2001

More information

Guidelines for Gamma Irradiation of Blood Components

Guidelines for Gamma Irradiation of Blood Components AUSTRALIAN & NEW ZEALAND SOCIETY OF BLOOD TRANSFUSION INC. AUSTRALIAN RED CROSS BLOOD SERVICE NEW ZEALAND BLOOD SERVICE Guidelines for Gamma Irradiation of Blood Components Revised 2003 AN ZS B T Australian

More information

Transplantation - Challenges for the future. Dr Gordon Cook S t James s Institute of Oncology, Leeds Teaching Hospitals Trust

Transplantation - Challenges for the future. Dr Gordon Cook S t James s Institute of Oncology, Leeds Teaching Hospitals Trust Transplantation - Challenges for the future Dr Gordon Cook S t James s Institute of Oncology, Leeds Teaching Hospitals Trust Bone Marrow Transplantation Timeline, 1957-2006 Appelbaum F. N Engl J Med 2007;357:1472-1475

More information

DEPARTMENT OF CLINICAL HEMATOLOGY

DEPARTMENT OF CLINICAL HEMATOLOGY DEPARTMENT OF CLINICAL HEMATOLOGY What is blood? Blood is the vital fluid of the body, which performs diverse functions from delivering oxygen to each and every cell of the body to fighting against infections

More information

Donatore HLA identico di anni o MUD giovane?

Donatore HLA identico di anni o MUD giovane? Donatore HLA identico di 60-70 anni o MUD giovane? Stella Santarone Dipartimento di Ematologia, Medicina Trasfusionale e Biotecnologie Pescara AGENDA 1. Stem Cell Donation: fatalities and severe events

More information

Title: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION

Title: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION Title: SECTION 7.0 NZBMDR STANDARDS PROCESS FOR DONOR IDENTIFICATION Authorised by: Executive Officer Contributing Authors: ABMDR Scientific Expert Advisory Committee Sally Gordon Dr Hilary Blacklock Raewyn

More information